Chad: WHO and UNICEF estimates of immunization coverage: 2022 revision

July 1, 2023; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad: WHO and UNICEF estimates of immunization coverage: 2022 revision

BACKGROUND NOTE: Each year WHO and UNICEF jointly review reports submitted by Member immunization and/or campaign or (ii) a sequential schedule of IPV followed by OPV, WHO and
States regarding national immunization coverage, finalized survey reports as well as data from the UNICEF estimates for IPV1 reflect coverage with at least one routine dose of IPV among infants
published and grey literature. Based on these data, with due consideration to potential biases and the <1 year of age among countries. For countries utilizing IPV containing vaccine use only, i.e., no
views of local experts, WHO and UNICEF attempt to distinguish between situations where the recommended dose of OPV, the WHO and UNICEF estimate for IPV1 corresponds to coverage
available empirical data accurately reflect immunization system performance and those where the data for the 1st dose of IPV.
are likely to be compromised and present a misleading view of immunization coverage while jointly Production of IPV coverage estimates, which begins in 2015, results in no change of the
estimating the most likely coverage levels for each country. estimated coverage levels for the 3rd dose of polio (Pol3). For countries recommending routine
immunization with a primary series of three doses of IPV alone, WHO and UNICEF estimated
WHO and UNICEF estimates are country-specific; that is to say, each country’s data are reviewed Pol3 coverage is equivalent to estimated coverage with three doses of IPV. For countries with a
individually, and data are not borrowed from other countries in the absence of data. Estimates are not sequential schedule, estimated Pol3 coverage is based on that for the 3rd dose of polio vaccine
based on ad hoc adjustments to reported data; in some instances empirical data are available from a regardless of vaccine type.
single source, usually the nationally reported coverage data. In cases where no data are available for a MCV1: percentage of surviving infants who received the 1st dose of measles containing vaccine. In
given country/vaccine/year combination, data are considered from earlier and later years and countries where the national schedule recommends the 1st dose of MCV at 12 months or later
interpolated to estimate coverage for the missing year(s). In cases where data sources are mixed and based on the epidemiology of disease in the country, coverage estimates reflect the percentage of
show large variation, an attempt is made to identify the most likely estimate with consideration of the children who received the 1st dose of MCV as recommended.
possible biases in available data. For methods see:
MCV2: percentage of children who received the 2nd dose of measles containing vaccine according to
*Burton et al. 2009. WHO and UNICEF estimates of national infant immunization coverage: methods the nationally recommended schedule.
and processes.
RCV1: percentage of surviving infants who received the 1st dose of rubella containing vaccine. Co
*Burton et al. 2012. A formal representation of the WHO and UNICEF estimates of national
verage estimates are based on WHO and UNICEF estimates of coverage for the dose of measles
immunization coverage: a computational logic approach.
containing vaccine that corresponds to the first measles-rubella combination vaccine. Nationally
*Brown et al. 2013. An introduction to the grade of confidence used to characterize uncertainty around
reported coverage of RCV is not taken into consideration nor are the data represented in the
the WHO and UNICEF estimates of national immunization coverage.
accompanying graph and data table.
HepBB: percentage of births which received a dose of hepatitis B vaccine within 24 hours of delivery.
DATA SOURCES.
Estimates of hepatitis B birth dose coverage are produced only for countries with a universal
ADMINISTRATIVE coverage: Reported by national authorities and based on aggregated birth dose policy. Estimates are not produced for countries that recommend a birth dose to
administrative reports from health service providers on the number of vaccinations administered infants born to HepB virus-infected mothers only or where there is insufficient information to
during a given period (numerator data) and reported target population data (denominator data). determine whether vaccination is within 24 hours of birth.
May be biased by inaccurate numerator and/or denominator data. HepB3: percentage of surviving infants who received the 3rd dose of hepatitis B containing vaccine
OFFICIAL coverage: Estimated coverage reported by national authorities that reflects their following the birth dose.
assessment of the most likely coverage based on any combination of administrative coverage, Hib3: percentage of surviving infants who received the 3rd dose of Haemophilus influenzae type b
survey-based estimates or other data sources or adjustments. Approaches to determine containing vaccine.
OFFICIAL coverage may differ across countries.
RotaC: percentage of surviving infants who received the final recommended dose of rotavirus vaccine,
SURVEY coverage: Based on estimated coverage from population-based household surveys among which can be either the 2nd or the 3rd dose depending on the vaccine.
children aged 12-23 months or 24-35 months following a review of survey methods and results. PcV3: percentage of surviving infants who received the 3rd dose of pneumococcal conjugate vaccine.
Information is based on the combination of vaccination history from documented evidence or In countries where the national schedule recommends two doses during infancy and a booster
caregiver recall. Survey results are considered for the appropriate birth cohort based on the dose at 12 months or later based on the epidemiology of disease in the country, coverage
period of data collection. estimates may reflect the percentage of surviving infants who received two doses of PcV prior to
the 1st birthday.
ABBREVIATIONS YFV: percentage of surviving infants who received one dose of yellow fever vaccine in countries where
BCG: percentage of births who received one dose of Bacillus Calmette Guerin vaccine. YFV is part of the national immunization schedule for children or is recommended in at risk
areas; coverage estimates are annualized for the entire cohort of surviving infants.
DTP1 / DTP3: percentage of surviving infants who received the 1st / 3rd dose, respectively, of
diphtheria and tetanus toxoid with pertussis containing vaccine. Disclaimer: All reasonable precautions have been taken by the World Health Organization and
Pol3: percentage of surviving infants who received the 3rd dose of polio containing vaccine. May be United Nations Children’s Fund to verify the information contained in this publication. However,
either oral or inactivated polio vaccine. the published material is being distributed without warranty of any kind, either expressed or
implied. The responsibility for the interpretation and use of the material lies with the reader. In
IPV1: percentage of surviving infants who received at least one dose of inactivated polio vaccine. In
no event shall the World Health Organization or United Nations Children’s Fund be liable for
countries utilizing an immunization schedule recommending either (i) a primary series of three
damages arising from its use.
doses of oral polio vaccine (OPV) plus at least one dose of IPV where OPV is included in routine

July 1, 2023; page 2 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - BCG
Description:

2022: Estimate informed by the difference between reported DTP1 and BCG coverage applied
to estimated DTP1 coverage. Programme notes challenges with the availability of data
recording tools and training of health centre managers in data verification and analysis.
Also, data review and validation meetings are not systematically held at all levels. WHO
and UNICEF encourage continued efforts to improve recording and monitoring while also
increasing coverage. WHO and UNICEF recommend a high-quality vaccination cover-
age survey and encourage the conduction of the national immunization coverage survey
planned for 2023. Estimate challenged by: D-R-
2021: Estimate is based on the difference between reported DTP1 and BCG coverage applied to
estimated DTP1 coverage. Estimate challenged by: D-R-
2020: Estimate is based on the difference between reported DTP1 and BCG coverage applied
to DTP1 estimates. Reported target population declined between 2019 and 2020. Im-
munization estimates from MICS survey could not be produced due to an error in data
collection. Estimate challenged by: D-R-
2019: Estimate is based on the difference between reported DTP1 and BCG coverage applied
to DTP1 estimates. Reported data suggests recovery following vaccine supply disrup-
tion in 2018 in spite of reported national and district level vaccine stockout of less than
one month duration during 2019. Reported coverage levels continue to suggest chal-
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 lenges within the administrative recording and reporting system. Programme notes that
Estimate 53 62 60 58 70 59 59 26 51 60 67 67 health center managers are insufficiently trained in data verification and analysis and
Estimate GoC • • • • • • • • • • • •
that data review and validation meetings are not systematically held at all levels. WHO
Official 79 79 75 85 96 75 60 51 76 85 92 92
Administrative 79 89 88 85 96 84 66 51 76 85 92 92
and UNICEF encourage continued efforts to improve recording and monitoring while also
Survey 68 NA 59.6 NA NA 59 NA NA NA NA NA NA increasing coverage. Estimate challenged by: D-R-
2018: Estimate is based on the difference between reported DTP1 and BCG coverage applied
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information to DTP1 estimates. Programme reports a 2.5 month vaccine stockout at national level.
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
Estimate challenged by: D-R-S-
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence 2017: Estimate of 59 percent assigned by working group. Estimate is based on survey result.
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around Decline in reported coverage is due in part to 25 percent increase in target population
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. between 2016 and 2017. Programme reports a five months vaccine stockout. Estimate
challenged by: D-R-
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator 2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
evidence of 59 percent based on 1 survey(s). Programme reports two months national
of being wrong. vaccine stockout. Reported official estimates inconsistent with administrative data. Es-
timate challenged by: D-R-
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. 2015: Reported data calibrated to 2013 and 2016 levels. Recovery from prior year stockout.
Estimate challenged by: D-R-S-
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
In all cases these estimates should be used with caution and should be assessed in light
supportive supervision and outreach activities, the programme has established a system
of the objective for which they are being used. of monthly monitoring of performance indicators backed by regular monitoring through
additional supportive supervisory visits. A National programme reports two months
stockout at national level. Estimate challenged by: D-R-

July 1, 2023; page 3 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - BCG

2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 60 percent based on 1 survey(s). Programme reports stockouts for all antigens
at the district level (duration unknown and number of districts unknown). Government
official estimate reflects an adjustment based on a preliminary sub-national coverage
survey results. Estimate challenged by: D-R-
2012: Reported data calibrated to 2009 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-
2011: Reported data calibrated to 2009 and 2013 levels. Chad Vaccination Coverage Survey 2012
results ignored by working group. BCG card only coverage of 57 percent is inconsistent
with card retention rate of 41 percent.. Estimate of 53 percent changed from previous
revision value of 52 percent. Estimate challenged by: D-R-

July 1, 2023; page 4 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - DTP1
Description:

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a one month vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Reported target population declined between 2019
and 2020. Immunization estimates from MICS survey could not be produced due to an
error in data collection. Programme reports district level vaccine stockout of unspecified
duration. Estimate challenged by: D-R-
2019: Reported data calibrated to 2017 levels. Reported coverage levels continue to suggest
challenges within the administrative recording and reporting system. Programme notes
that health center managers are insufficiently trained in data verification and analysis
and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 while also increasing coverage. Estimate challenged by: D-R-
Estimate 55 57 58 63 59 55 55 61 65 69 73 74 2018: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
Estimate GoC • • • • • • • • • • • •
2017: Estimate of 55 percent assigned by working group. Estimate is based on survey result.
Official NA 93 98 99 107 90 80 86 90 94 98 99
Administrative 94 103 103 99 107 104 85 86 90 94 98 99
Decline in reported coverage is due in part to 25 percent increase in target population
Survey 55 NA 58.3 NA NA 55 NA NA NA NA NA NA between 2016 and 2017. Estimate challenged by: D-R-
2016: Survey evidence does not support reported data. Estimate based on survey results. Sur-
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information vey evidence of 55 percent based on 1 survey(s). Reported data excluded because 104
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
percent greater than 100 percent. Reported official estimates inconsistent with adminis-
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence trative data. Estimate challenged by: D-R-
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around 2015: Reported data calibrated to 2013 and 2016 levels. Reported data excluded because 107
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. percent greater than 100 percent. Estimate challenged by: D-R-
2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator supportive supervision and outreach activities, the programme has established a system
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of monthly monitoring of performance indicators backed by regular monitoring through
of being wrong. additional supportive supervisory visits. A Estimate challenged by: D-R-
2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. evidence of 58 percent based on 1 survey(s). Reported data excluded because 103 percent
greater than 100 percent. Programme reports stockouts for all antigens at the district
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. level (duration unknown and number of districts unknown). Government official esti-
In all cases these estimates should be used with caution and should be assessed in light
mate reflects an adjustment based on a preliminary sub-national coverage survey results.
of the objective for which they are being used. Estimate challenged by: D-R-
2012: Reported data calibrated to 2011 and 2013 levels. Reported data excluded because 103
percent greater than 100 percent. Government official estimate reflects an adjustment

July 1, 2023; page 5 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - DTP1

based on survey results. Estimate challenged by: D-R-

2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 55 percent based on 1 survey(s). . Estimate challenged by: D-R-

July 1, 2023; page 6 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - DTP3
Description:

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a one month vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Reported target population declined between 2019
and 2020. Immunization estimates from MICS survey could not be produced due to an
error in data collection. Programme reports district level vaccine stockout of unspecified
duration. Estimate challenged by: D-R-
2019: Reported data calibrated to 2017 levels. Reported coverage levels continue to suggest
challenges within the administrative recording and reporting system. Programme notes
that health center managers are insufficiently trained in data verification and analysis
and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 while also increasing coverage. Estimate challenged by: D-R-
Estimate 33 40 39 36 42 41 41 46 50 52 58 60 2018: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
Estimate GoC • • • • • • • • • • • •
2017: Estimate of 41 percent assigned by working group. Estimate is based on survey result.
Official 70 72 70 83 92 78 72 77 81 83 89 91
Administrative 70 82 85 83 92 92 77 77 81 83 89 91
Decline in reported coverage is due in part to 25 percent increase in target population
Survey 42 NA 33.2 NA NA 37 NA NA NA NA NA NA between 2016 and 2017. Estimate challenged by: D-R-
2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information evidence of 41 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2017
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
card or history results of 37 percent modifed for recall bias to 41 percent based on 1st
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence dose card or history coverage of 55 percent, 1st dose card only coverage of 24 percent
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around and 3rd dose card only coverage of 18 percent. Reported official estimates inconsistent
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. with administrative data. Estimate challenged by: D-R-
2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
supportive supervision and outreach activities, the programme has established a system
of being wrong. of monthly monitoring of performance indicators backed by regular monitoring through
additional supportive supervisory visits. A Estimate challenged by: D-R-
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. 2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 39 percent based on 1 survey(s). Chad Joint DHS and MICS 2015 card or
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. history results of 33 percent modifed for recall bias to 39 percent based on 1st dose card
In all cases these estimates should be used with caution and should be assessed in light
or history coverage of 58 percent, 1st dose card only coverage of 31 percent and 3rd dose
of the objective for which they are being used. card only coverage of 21 percent. Programme reports stockouts for all antigens at the
district level (duration unknown and number of districts unknown). Government offi-
cial estimate reflects an adjustment based on a preliminary sub-national coverage survey

July 1, 2023; page 7 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - DTP3

results. Estimate challenged by: D-R-

2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 33 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2012
card or history results of 42 percent modifed for recall bias to 33 percent based on 1st
dose card or history coverage of 55 percent, 1st dose card only coverage of 15 percent
and 3rd dose card only coverage of 9 percent. . Estimate challenged by: D-R-

July 1, 2023; page 8 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - Pol3
Description:

2022: Estimate informed by the ratio of the reported number of administered Pol3 doses to
DTP3 doses applied to the estimated DTP3 coverage level. Programme notes challenges
with the availability of data recording tools and training of health centre managers in
data verification and analysis. Also, data review and validation meetings are not system-
atically held at all levels. WHO and UNICEF encourage continued efforts to improve
recording and monitoring while also increasing coverage. WHO and UNICEF recommend
a high-quality vaccination coverage survey and encourage the conduction of the national
immunization coverage survey planned for 2023. Estimate challenged by: D-R-
2021: Estimate is based on the ratio of the reported number of administered Pol3 doses to DTP3
doses applied to the estimated DTP3 coverage level. Estimate challenged by: D-R-
2020: Estimate is based on the ratio of the reported number of administered Pol3 doses to
DTP3 doses applied to the estimated DTP3 coverage level. Reported target population
declined between 2019 and 2020. Immunization estimates from MICS survey could not
be produced due to an error in data collection. Estimate challenged by: D-R-
2019: Estimate is based on the ratio of the reported number of administered Pol3 doses to DTP3
doses applied to the estimated DTP3 coverage level. Reported coverage levels continue
to suggest challenges within the administrative recording and reporting system. Pro-
gramme notes that health center managers are insufficiently trained in data verification
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 and analysis and that data review and validation meetings are not systematically held
Estimate 40 51 46 44 52 44 44 41 47 52 58 57 at all levels. WHO and UNICEF encourage continued efforts to improve recording and
Estimate GoC • • • • • • • • • • • •
monitoring while also increasing coverage. Estimate challenged by: D-R-
Official 67 73 70 81 89 75 58 76 75 82 87 88
Administrative 67 83 83 81 89 81 63 76 75 82 87 88
2018: Reported data calibrated to 2017 levels. Estimate challenged by: R-
Survey 52 NA 49.5 NA NA 43 NA NA NA NA NA NA 2017: Estimate of 44 percent assigned by working group. Estimate is based on survey result.
Reported data excluded due to decline in reported coverage from 81 percent to 58 percent
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information with increase to 76 percent. Decline in reported coverage is due in part to 25 percent
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
increase in target population between 2016 and 2017. Estimate challenged by: D-R-
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence 2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around evidence of 44 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2017
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. card or history results of 43 percent modifed for recall bias to 44 percent based on 1st dose
card or history coverage of 61 percent, 1st dose card only coverage of 22 percent and 3rd
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator dose card only coverage of 16 percent. Programme reports two months national vaccine
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
stockout. Reported official estimates inconsistent with administrative data. Estimate
of being wrong. challenged by: D-R-
2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
supportive supervision and outreach activities, the programme has established a system
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. of monthly monitoring of performance indicators backed by regular monitoring through
In all cases these estimates should be used with caution and should be assessed in light
additional supportive supervisory visits. A Estimate challenged by: D-R-S-
of the objective for which they are being used. 2013: Estimate of 46 percent assigned by working group. Estimate based on DTP3 coverage.
Survey results may include OPV campaign doses. Chad Joint DHS and MICS 2015 card
or history results of 50 percent modifed for recall bias to 55 percent based on 1st dose

July 1, 2023; page 9 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - Pol3

card or history coverage of 76 percent, 1st dose card only coverage of 30 percent and 3rd
dose card only coverage of 22 percent. Programme reports stockouts for all antigens at
the district level (duration unknown and number of districts unknown). Government offi-
cial estimate reflects an adjustment based on a preliminary sub-national coverage survey
results. Estimate challenged by: D-R-
2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-S-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 40 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2012
card or history results of 52 percent modifed for recall bias to 40 percent based on 1st
dose card or history coverage of 68 percent, 1st dose card only coverage of 17 percent
and 3rd dose card only coverage of 10 percent. . Estimate challenged by: D-R-S-

July 1, 2023; page 10 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - IPV1
Description:

Estimates for a dose of inactivated polio vaccine (IPV) begin in 2015 following the Global Po-
lio Eradication Initiative’s Polio Eradication and Endgame Strategic Plan: 2013-2018
which recommended at least one full dose or two fractional doses of IPV into routine
immunization schedules as a strategy to mitigate the potential consequences should any
re-emergence of type 2 poliovirus occur following the planned withdrawal of Sabin type
2 strains from oral polio vaccine (OPV).

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Reported target population declined between 2019
and 2020. Immunization estimates from MICS survey could not be produced due to an
error in data collection. Programme reports district level vaccine stockout of unspecified
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 duration. Estimate challenged by: D-R-
Estimate NA NA NA NA 28 41 41 48 49 51 59 61 2019: Reported data calibrated to 2017 levels. Reported coverage levels continue to suggest
Estimate GoC NA NA NA NA • • • • • • • •
challenges within the administrative recording and reporting system. Programme notes
Official NA NA NA NA 28 75 70 77 78 80 88 90
Administrative NA NA NA NA 28 82 71 77 78 80 88 90
that health center managers are insufficiently trained in data verification and analysis
Survey NA NA NA NA NA NA NA NA NA NA NA NA and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information while also increasing coverage. Estimate challenged by: D-R-
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
2018: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence 2017: Estimate of 41 percent assigned by working group. Estimate is based on survey result.
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around Decline in reported coverage is due in part to 25 percent increase in target population
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. between 2016 and 2017. Estimate challenged by: D-R-
2016: Estimate of 41 percent assigned by working group. Estimate based on DTP3 coverage
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator estimate. Reported data excluded due to an increase from 28 percent to 82 percent with
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
decrease 70 percent. Reported official estimates inconsistent with administrative data.
of being wrong. Estimate challenged by: D-R-
2015: Inactivated polio vaccine in August 2015. Estimate is exceptionally based on reported
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. data. GoC=Assigned by working group. .

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 11 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - MCV1
Description:

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a two months vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Survey results ignored. Sample size 94 less
than 300. Reported target population declined between 2019 and 2020. Immunization
estimates from MICS survey could not be produced due to an error in data collection.
Estimate challenged by: D-R-
2019: Reported data calibrated to 2017 levels. Evaluation of the Vaccination Campaign Against
Measles in Chad 2022 results ignored by working group. Post-campaign coverage survey
of older children with low levels of documented evidence. Survey results suggest lower
coverage. Reported coverage levels continue to suggest challenges within the administra-
tive recording and reporting system. Programme notes that health center managers are
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 insufficiently trained in data verification and analysis and that data review and valida-
Estimate 54 63 57 45 46 37 37 42 41 47 55 56 tion meetings are not systematically held at all levels. WHO and UNICEF encourage
Estimate GoC • • • • • • • • • • • •
continued efforts to improve recording and monitoring while also increasing coverage.
Official 79 69 65 79 NA 75 65 70 69 75 83 84
Administrative 79 89 84 79 87 85 68 70 69 75 83 84
Programme reports national and district level vaccine stockout of 1.1 month duration.
Survey 54 NA 56.9 NA NA 37 NA NA 28.2 41.1 NA NA Estimate challenged by: D-R-
2018: Reported data calibrated to 2017 levels. Programme reports one month vaccine stockout
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information at national level. Estimate challenged by: D-R-
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
2017: Estimate of 37 percent assigned by working group. Estimate is based on survey result.
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence Decline in reported coverage is due in part to 25 percent increase in target population
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around between 2016 and 2017. Estimate challenged by: D-R-
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. 2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 37 percent based on 1 survey(s). Reported official estimates inconsistent with
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator administrative data. Estimate challenged by: D-R-
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-S-
of being wrong. 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
supportive supervision and outreach activities, the programme has established a system
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. of monthly monitoring of performance indicators backed by regular monitoring through
additional supportive supervisory visits. A Estimate challenged by: D-R-S-
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. 2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
In all cases these estimates should be used with caution and should be assessed in light
evidence of 57 percent based on 1 survey(s). Programme reports stockouts for all antigens
of the objective for which they are being used. at the district level (duration unknown and number of districts unknown). Government
official estimate reflects an adjustment based on a preliminary sub-national coverage
survey results. Estimate challenged by: D-R-

July 1, 2023; page 12 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - MCV1

2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: R-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 54 percent based on 1 survey(s). . Estimate challenged by: R-S-

July 1, 2023; page 13 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - MCV2
Description:

Coverage estimates for the second dose of measles containing vaccine are for children by the
nationally recommended age.

2022: Estimate informed by reported data. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a two months vaccine stockout
at national and subnational levels. Vaccine dose introduced in October 2021, reporting
started in 2022. GoC=R+ D+

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Estimate NA NA NA NA NA NA NA NA NA NA NA 2
Estimate GoC NA NA NA NA NA NA NA NA NA NA NA ••
Official NA NA NA NA NA NA NA NA NA NA NA 2
Administrative NA NA NA NA NA NA NA NA NA NA NA 2
Survey NA NA NA NA NA NA NA NA NA NA NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 14 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - RCV1

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Estimate NA NA NA NA NA NA NA NA NA NA NA NA
Estimate GoC NA NA NA NA NA NA NA NA NA NA NA NA
Official NA NA NA NA NA NA NA NA NA NA NA NA
Administrative NA NA NA NA NA NA NA NA NA NA NA NA
Survey NA NA NA NA NA NA NA NA NA NA NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 15 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - HepBB

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Estimate NA NA NA NA NA NA NA NA NA NA NA NA
Estimate GoC NA NA NA NA NA NA NA NA NA NA NA NA
Official NA NA NA NA NA NA NA NA NA NA NA NA
Administrative NA NA NA NA NA NA NA NA NA NA NA NA
Survey NA NA NA NA NA NA NA NA NA NA NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 16 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - HepB3
Description:

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a one month vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Reported target population declined between 2019
and 2020. Immunization estimates from MICS survey could not be produced due to an
error in data collection. Programme reports district level vaccine stockout of unspecified
duration. Estimate challenged by: D-R-
2019: Reported data calibrated to 2017 levels. Reported coverage levels continue to suggest
challenges within the administrative recording and reporting system. Programme notes
that health center managers are insufficiently trained in data verification and analysis
and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 while also increasing coverage. Estimate challenged by: D-R-
Estimate 33 40 39 36 42 41 41 46 50 52 58 60 2018: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
Estimate GoC • • • • • • • • • • • •
2017: Estimate of 41 percent assigned by working group. Estimate is based on survey result.
Official 70 72 70 83 92 78 72 77 81 83 89 91
Administrative 70 82 85 83 92 92 77 77 81 83 89 91
Decline in reported coverage is due in part to 25 percent increase in target population
Survey 42 NA 33.2 NA NA 37 NA NA NA NA NA NA between 2016 and 2017. Estimate challenged by: D-R-
2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information evidence of 41 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2017
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
card or history results of 37 percent modifed for recall bias to 41 percent based on 1st
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence dose card or history coverage of 55 percent, 1st dose card only coverage of 24 percent
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around and 3rd dose card only coverage of 18 percent. Reported official estimates inconsistent
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. with administrative data. Estimate challenged by: D-R-
2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
supportive supervision and outreach activities, the programme has established a system
of being wrong. of monthly monitoring of performance indicators backed by regular monitoring through
additional supportive supervisory visits. A Estimate challenged by: D-R-
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. 2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 39 percent based on 1 survey(s). Chad Joint DHS and MICS 2015 card or
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. history results of 33 percent modifed for recall bias to 39 percent based on 1st dose card
In all cases these estimates should be used with caution and should be assessed in light
or history coverage of 58 percent, 1st dose card only coverage of 31 percent and 3rd dose
of the objective for which they are being used. card only coverage of 21 percent. Programme reports stockouts for all antigens at the
district level (duration unknown and number of districts unknown). Government offi-
cial estimate reflects an adjustment based on a preliminary sub-national coverage survey

July 1, 2023; page 17 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - HepB3

results. Estimate challenged by: D-R-

2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 33 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2012
card or history results of 42 percent modifed for recall bias to 33 percent based on 1st
dose card or history coverage of 55 percent, 1st dose card only coverage of 15 percent
and 3rd dose card only coverage of 9 percent. . Estimate challenged by: D-R-S-

July 1, 2023; page 18 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - Hib3
Description:

2022: Reported data calibrated to 2017 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a one month vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
2020: Reported data calibrated to 2017 levels. Reported target population declined between 2019
and 2020. Immunization estimates from MICS survey could not be produced due to an
error in data collection. Programme reports district level vaccine stockout of unspecified
duration. Estimate challenged by: D-R-
2019: Reported data calibrated to 2017 levels. Reported coverage levels continue to suggest
challenges within the administrative recording and reporting system. Programme notes
that health center managers are insufficiently trained in data verification and analysis
and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 while also increasing coverage. Estimate challenged by: D-R-
Estimate 33 40 39 36 42 41 41 46 50 52 58 60 2018: Reported data calibrated to 2017 levels. Estimate challenged by: D-R-
Estimate GoC • • • • • • • • • • • •
2017: Estimate of 41 percent assigned by working group. Estimate is based on survey result.
Official 70 72 70 83 92 78 72 77 81 83 89 91
Administrative 70 82 85 83 92 92 75 77 81 83 89 91
Decline in reported coverage is due in part to 25 percent increase in target population
Survey 42 NA 33.2 NA NA 37 NA NA NA NA NA NA between 2016 and 2017. Estimate challenged by: D-R-
2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information evidence of 41 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2017
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
card or history results of 37 percent modifed for recall bias to 41 percent based on 1st
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence dose card or history coverage of 55 percent, 1st dose card only coverage of 24 percent
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around and 3rd dose card only coverage of 18 percent. Reported official estimates inconsistent
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. with administrative data. Estimate challenged by: D-R-
2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator 2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
supportive supervision and outreach activities, the programme has established a system
of being wrong. of monthly monitoring of performance indicators backed by regular monitoring through
additional supportive supervisory visits. A Estimate challenged by: D-R-
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. 2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 39 percent based on 1 survey(s). Chad Joint DHS and MICS 2015 card or
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. history results of 33 percent modifed for recall bias to 39 percent based on 1st dose card
In all cases these estimates should be used with caution and should be assessed in light
or history coverage of 58 percent, 1st dose card only coverage of 31 percent and 3rd dose
of the objective for which they are being used. card only coverage of 21 percent. Programme reports stockouts for all antigens at the
district level (duration unknown and number of districts unknown). Government offi-
cial estimate reflects an adjustment based on a preliminary sub-national coverage survey

July 1, 2023; page 19 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - Hib3

results. Estimate challenged by: D-R-

2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 33 percent based on 1 survey(s). Chad Vaccination Coverage Survey 2012
card or history results of 42 percent modifed for recall bias to 33 percent based on 1st
dose card or history coverage of 55 percent, 1st dose card only coverage of 15 percent
and 3rd dose card only coverage of 9 percent. . Estimate challenged by: D-R-

July 1, 2023; page 20 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - RotaC

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Estimate NA NA NA NA NA NA NA NA NA NA NA NA
Estimate GoC NA NA NA NA NA NA NA NA NA NA NA NA
Official NA NA NA NA NA NA NA NA NA NA NA NA
Administrative NA NA NA NA NA NA NA NA NA NA NA NA
Survey NA NA NA NA NA NA NA NA NA NA NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 21 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - PcV3

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Estimate NA NA NA NA NA NA NA NA NA NA NA NA
Estimate GoC NA NA NA NA NA NA NA NA NA NA NA NA
Official NA NA NA NA NA NA NA NA NA NA NA NA
Administrative NA NA NA NA NA NA NA NA NA NA NA NA
Survey NA NA NA NA NA NA NA NA NA NA NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
of being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in light
of the objective for which they are being used.

July 1, 2023; page 22 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - YFV
Description:

2022: Reported data calibrated to 2018 levels. Programme notes challenges with the availability
of data recording tools and training of health centre managers in data verification and
analysis. Also, data review and validation meetings are not systematically held at all
levels. WHO and UNICEF encourage continued efforts to improve recording and mon-
itoring while also increasing coverage. WHO and UNICEF recommend a high-quality
vaccination coverage survey and encourage the conduction of the national immunization
coverage survey planned for 2023. Programme reports a one month vaccine stockout at
national and subnational levels. Estimate challenged by: D-R-
2021: Reported data calibrated to 2018 levels. Programme reports one-half month vaccine stock-
out at national level. Estimate challenged by: D-R-
2020: Reported data calibrated to 2018 levels. Reported target population declined between
2019 and 2020. Immunization estimates from MICS survey could not be produced due
to an error in data collection. Estimate challenged by: D-R-
2019: Reported data calibrated to 2018 levels. Reported coverage levels continue to suggest
challenges within the administrative recording and reporting system. Programme notes
that health center managers are insufficiently trained in data verification and analysis
and that data review and validation meetings are not systematically held at all levels.
WHO and UNICEF encourage continued efforts to improve recording and monitoring
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 while also increasing coverage. Programme reports national and district level vaccine
Estimate 45 51 44 34 41 29 29 35 35 35 45 42 stockout of less than one month duration. Estimate challenged by: D-R-
Estimate GoC • • • • • • • • • • • •
2018: Estimate of 35 percent assigned by working group. Estimates based on trends seen in
Official 80 70 65 75 84 70 65 73 73 73 83 80
Administrative 80 88 84 75 84 73 67 73 73 73 83 80
reported data between 2017 and 2018. Programme reports one month vaccine stockout
Survey 45 NA 43.5 NA NA 29 NA NA NA NA NA NA at national level. Estimate challenged by: D-R-
2017: Estimate of 29 percent assigned by working group. Estimate is based on survey result.
The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information Reported data excluded. Estimate based on prior year estimate consistent with other
that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe
the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon
vaccines. Decline in reported coverage is due in part to 25 percent increase in target
which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence population between 2016 and 2017. Estimate challenged by: D-R-
intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around 2016: Survey evidence does not support reported data. Estimate based on survey results. Survey
the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is
not a judgment of the quality of data reported by national authorities. evidence of 29 percent based on 1 survey(s). Reported official estimates inconsistent with
administrative data. Estimate challenged by: D-R-
••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominator 2015: Reported data calibrated to 2013 and 2016 levels. Estimate challenged by: D-R-S-
from the World Population Prospects: 2022 revision from the UN Population Division (D+), and at
least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk
2014: Reported data calibrated to 2013 and 2016 levels. In conjunction with intensification of
of being wrong. supportive supervision and outreach activities, the programme has established a system
of monthly monitoring of performance indicators backed by regular monitoring through
•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or
[S-], challenges the estimate. additional supportive supervisory visits. A National programme reports two months
stockout at national level. Estimate challenged by: D-R-
• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. 2013: Survey evidence does not support reported data. Estimate based on survey results. Survey
In all cases these estimates should be used with caution and should be assessed in light
evidence of 44 percent based on 1 survey(s). Programme reports stockouts for all antigens
of the objective for which they are being used. at the district level (duration unknown and number of districts unknown). Government
official estimate reflects an adjustment based on a preliminary sub-national coverage
survey results. Estimate challenged by: D-R-

July 1, 2023; page 23 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - YFV

2012: Reported data calibrated to 2011 and 2013 levels. Government official estimate reflects an
adjustment based on survey results. Estimate challenged by: D-R-
2011: Survey evidence does not support reported data. Estimate based on survey results. Survey
evidence of 45 percent based on 1 survey(s). . Estimate challenged by: D-R-S-

July 1, 2023; page 24 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - survey details
NOTE: A survey to measure vaccination coverage for infants (i.e., children 2017 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad
aged 0 to 11 months) will sample children aged 12 to 23 months at the 2022
time of survey to capture the youngest annual cohort of children who
should have completed the vaccination schedule. Because WUENIC are for
infant vaccinations, survey data in this report are presented to reflect Vaccine Confirmation method Coverage Age cohort Sample Cards seen
the birth year of the youngest survey cohort. For example, results for a MCV1 Card 1.9 48-59 m 2744 11
survey conducted during December 2020 among children aged 12 to 23 months MCV1 Card or History 21.9 48-59 m 2744 11
at the time of the survey reflect the immunization experience of children MCV1 History 20 48-59 m 2744 11
born in 2019. Depending on the timing of survey field work, results may
reflect the immunization experience of children born and vaccinated 1 or 2
years prior to the survey field work. 2016 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad
2022
2020 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad
2022 Vaccine Confirmation method Coverage Age cohort Sample Cards seen
MCV1 Card 1.7 60-71 m 1399 11
Vaccine Confirmation method Coverage Age cohort Sample Cards seen MCV1 Card or History 17.4 60-71 m 1399 11
MCV1 Card 2.5 12-23 m 94 11 MCV1 History 15.7 60-71 m 1399 11
MCV1 Card or History 41.1 12-23 m 94 11
MCV1 History 38.6 12-23 m 94 11
2016 L’Enquête de Couverture Vaccinale, Tchad, 2017

2019 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad

Vaccine Confirmation method Coverage Age cohort Sample Cards seen
2022
BCG Card 23 12-23 m 10083 28
BCG Card or History 59 12-23 m 10083 28
Vaccine Confirmation method Coverage Age cohort Sample Cards seen DTP1 Card 24 12-23 m 10083 28
MCV1 Card 1.9 24-35 m 3111 11 DTP1 Card or History 55 12-23 m 10083 28
MCV1 Card or History 28.2 24-35 m 3111 11 DTP3 Card 18 12-23 m 10083 28
MCV1 History 23.6 24-35 m 3111 11 DTP3 Card or History 37 12-23 m 10083 28
HepB1 Card 24 12-23 m 10083 28
HepB1 Card or History 55 12-23 m 10083 28
2018 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad HepB3 Card 18 12-23 m 10083 28
2022 HepB3 Card or History 37 12-23 m 10083 28
Hib1 Card 24 12-23 m 10083 28
Vaccine Confirmation method Coverage Age cohort Sample Cards seen Hib1 Card or History 55 12-23 m 10083 28
MCV1 Card 2.5 36-47 m 3995 11 Hib3 Card 18 12-23 m 10083 28
MCV1 Card or History 26.5 36-47 m 3995 11 Hib3 Card or History 37 12-23 m 10083 28
MCV1 History 24 36-47 m 3995 11 MCV1 Card 15 12-23 m 10083 28
MCV1 Card or History 37 12-23 m 10083 28

July 1, 2023; page 25 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - survey details

Pol1 Card 22 12-23 m 10083 28 Hib3 C or H <12 months 28.4 12-23 m 2953 32
Pol1 Card or History 61 12-23 m 10083 28 Hib3 Card 20.5 12-23 m 954 32
Pol3 Card 16 12-23 m 10083 28 Hib3 Card or History 33.2 12-23 m 2953 32
Pol3 Card or History 43 12-23 m 10083 28 MCV1 C or H <12 months 39.8 12-23 m 2953 32
YFV Card 13 12-23 m 10083 28 MCV1 Card 24.7 12-23 m 954 32
YFV Card or History 29 12-23 m 10083 28 MCV1 Card or History 56.9 12-23 m 2953 32
Pol1 C or H <12 months 70.4 12-23 m 2953 32
Pol1 Card 30.1 12-23 m 954 32
2015 Evaluation de la Campagne de Vaccination contre la Rougeole au Tchad Pol1 Card or History 76.3 12-23 m 2953 32
2022 Pol3 C or H <12 months 42.6 12-23 m 2953 32
Pol3 Card 21.6 12-23 m 954 32
Pol3 Card or History 49.5 12-23 m 2953 32
Vaccine Confirmation method Coverage Age cohort Sample Cards seen YFV C or H <12 months 31.9 12-23 m 2953 32
MCV1 Card 0.8 72-76 m 257 11 YFV Card 19.4 12-23 m 954 32
MCV1 Card or History 14.9 72-76 m 257 11 YFV Card or History 43.5 12-23 m 2953 32
MCV1 History 14.1 72-76 m 257 11

2012 Enquete demographique et de sante et a indicateurs multiples au Tchad

2013 Enquete demographique et de sante et a indicateurs multiples au Tchad 2014-15
2014-15
Vaccine Confirmation method Coverage Age cohort Sample Cards seen
Vaccine Confirmation method Coverage Age cohort Sample Cards seen BCG C or H <12 months 50.6 24-35 m 3232 32
BCG C or H <12 months 55.2 12-23 m 2953 32 DTP1 C or H <12 months 43.8 24-35 m 3232 32
BCG Card 29.3 12-23 m 954 32 DTP3 C or H <12 months 25 24-35 m 3232 32
BCG Card or History 59.6 12-23 m 2953 32 HepB1 C or H <12 months 43.8 24-35 m 3232 32
DTP1 C or H <12 months 53.4 12-23 m 2953 32 HepB3 C or H <12 months 25 24-35 m 3232 32
DTP1 Card 30.5 12-23 m 954 32 Hib1 C or H <12 months 43.8 24-35 m 3232 32
DTP1 Card or History 58.3 12-23 m 2953 32 Hib3 C or H <12 months 25 24-35 m 3232 32
DTP3 C or H <12 months 28.4 12-23 m 2953 32 MCV1 C or H <12 months 30.8 24-35 m 3232 32
DTP3 Card 20.5 12-23 m 954 32 Pol1 C or H <12 months 61 24-35 m 3232 32
DTP3 Card or History 33.2 12-23 m 2953 32 Pol3 C or H <12 months 41.8 24-35 m 3232 32
HepB1 C or H <12 months 53.4 12-23 m 2953 32
HepB1 Card 30.5 12-23 m 954 32
HepB1 Card or History 58.3 12-23 m 2953 32
2011 L’Enquête de Couverture Vaccinale, Tchad, 2012
HepB3 C or H <12 months 28.4 12-23 m 2953 32
HepB3 Card 20.5 12-23 m 954 32 Vaccine Confirmation method Coverage Age cohort Sample Cards seen
HepB3 Card or History 33.2 12-23 m 2953 32 BCG C or H <12 months 27 12-23 m 7343 41
Hib1 C or H <12 months 53.4 12-23 m 2953 32 BCG Card 57 12-23 m - 41
Hib1 Card 30.5 12-23 m 954 32 BCG Card or History 68 12-23 m 7343 41
Hib1 Card or History 58.3 12-23 m 2953 32 DTP1 C or H <12 months 32 12-23 m 7343 41

July 1, 2023; page 26 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - survey details

DTP1 Card 15 12-23 m - 41 DTP1 Card or History 45.4 12-23 m 2932 21

DTP1 Card or History 55 12-23 m 7343 41 DTP1 History 26.3 12-23 m - 21
DTP3 C or H <12 months 14 12-23 m 7343 41 DTP3 C or H <12 months 15.5 12-23 m - 21
DTP3 Card 9 12-23 m - 41 DTP3 Card 10.5 12-23 m - 21
DTP3 Card or History 42 12-23 m 7343 41 DTP3 Card or History 19.7 12-23 m 2932 21
HepB1 C or H <12 months 32 12-23 m 7343 41 DTP3 History 9.2 12-23 m - 21
HepB1 Card 15 12-23 m - 41 HepB1 C or H <12 months 32.5 12-23 m - 21
HepB1 Card or History 55 12-23 m 7343 41 HepB1 Card 19.4 12-23 m - 21
HepB3 C or H <12 months 14 12-23 m 7343 41 HepB1 Card or History 35.2 12-23 m 2932 21
HepB3 Card 9 12-23 m - 41 HepB1 History 15.8 12-23 m - 21
HepB3 Card or History 42 12-23 m 7343 41 HepB3 C or H <12 months 11.1 12-23 m - 21
Hib1 C or H <12 months 32 12-23 m 7343 41 HepB3 Card 10.6 12-23 m - 21
Hib1 Card 15 12-23 m - 41 HepB3 Card or History 14.1 12-23 m 2932 21
Hib1 Card or History 55 12-23 m 7343 41 HepB3 History 3.4 12-23 m - 21
Hib3 C or H <12 months 14 12-23 m 7343 41 MCV1 C or H <12 months 30.1 12-23 m - 21
Hib3 Card 9 12-23 m - 41 MCV1 Card 12.5 12-23 m - 21
Hib3 Card or History 42 12-23 m 7343 41 MCV1 Card or History 36 12-23 m 2932 21
MCV1 C or H <12 months 18 12-23 m 7343 41 MCV1 History 23.5 12-23 m - 21
MCV1 Card 13 12-23 m - 41 Pol1 C or H <12 months 56.4 12-23 m - 21
MCV1 Card or History 54 12-23 m 7343 41 Pol1 Card 18.8 12-23 m - 21
Pol1 C or H <12 months 39 12-23 m 7343 41 Pol1 Card or History 61.3 12-23 m 2932 21
Pol1 Card 17 12-23 m - 41 Pol1 History 42.5 12-23 m - 21
Pol1 Card or History 68 12-23 m 7343 41 Pol3 C or H <12 months 25 12-23 m - 21
Pol3 C or H <12 months 17 12-23 m 7343 41 Pol3 Card 10.3 12-23 m - 21
Pol3 Card 10 12-23 m - 41 Pol3 Card or History 31.8 12-23 m 2932 21
Pol3 Card or History 52 12-23 m 7343 41 Pol3 History 21.5 12-23 m - 21
YFV C or H <12 months 24 12-23 m 7343 41 YFV C or H <12 months 25.5 12-23 m - 21
YFV Card 9 12-23 m - 41 YFV Card 10.1 12-23 m - 21
YFV Card or History 45 12-23 m 7343 41 YFV Card or History 32 12-23 m 2932 21
YFV History 21.9 12-23 m - 21

2009 Enquête par grappes à indicateurs multiples MICS Tchad 2010

2003 L’Enquête Démographique et de Santé au Tchad, 2004
Vaccine Confirmation method Coverage Age cohort Sample Cards seen
BCG C or H <12 months 43.8 12-23 m - 21 Vaccine Confirmation method Coverage Age cohort Sample Cards seen
BCG Card 16.2 12-23 m - 21 BCG C or H <12 months 36.5 12-23 m 941 24
BCG Card or History 46.5 12-23 m 2932 21 BCG Card 20.3 12-23 m 941 24
BCG History 30.3 12-23 m - 21 BCG Card or history 40.2 12-23 m 941 24
DTP1 C or H <12 months 42 12-23 m - 21 BCG History 19.9 12-23 m 941 24
DTP1 Card 19.1 12-23 m - 21 DTP1 C or H <12 months 41.5 12-23 m 941 24

July 1, 2023; page 27 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - survey details
DTP1 Card 23.6 12-23 m 941 24
DTP1 Card or history 44.6 12-23 m 941 24
DTP1 History 21 12-23 m 941 24 1999 République du Tchad, Enquête de grappes à indicateurs multiples,
DTP3 C or H <12 months 15.9 12-23 m 941 24 Rapport complet, 2000
DTP3 Card 11.6 12-23 m 941 24
DTP3 Card or history 20.1 12-23 m 941 24
DTP3 History 8.5 12-23 m 941 24 Vaccine Confirmation method Coverage Age cohort Sample Cards seen
MCV1 C or H <12 months 14.8 12-23 m 941 24 BCG C or H <12 months 42 12-23 m 873 23
MCV1 Card 13.6 12-23 m 941 24 BCG Card 9.8 12-23 m 873 23
MCV1 Card or history 22.8 12-23 m 941 24 BCG Card or History 45.4 12-23 m 873 23
MCV1 History 9.2 12-23 m 941 24 BCG History 35.6 12-23 m 873 23
Pol1 C or H <12 months 73.1 12-23 m 941 24 DTP1 C or H <12 months 42.8 12-23 m 873 23
Pol1 Card 23 12-23 m 941 24 DTP1 Card 9.8 12-23 m 873 23
Pol1 Card or history 78 12-23 m 941 24 DTP1 Card or History 45.1 12-23 m 873 23
Pol1 History 55 12-23 m 941 24 DTP1 History 35.3 12-23 m 873 23
Pol3 C or H <12 months 28.1 12-23 m 941 24 DTP3 C or H <12 months 17.3 12-23 m 873 23
Pol3 Card 12.3 12-23 m 941 24 DTP3 Card 10.5 12-23 m 873 23
Pol3 Card or history 35.5 12-23 m 941 24 DTP3 Card or History 20.7 12-23 m 873 23
Pol3 History 23.2 12-23 m 941 24 DTP3 History 10.2 12-23 m 873 23
YFV C or H <12 months 14.1 12-23 m 941 24 MCV1 C or H <12 months 24.5 12-23 m 873 23
YFV Card 13.5 12-23 m 941 24 MCV1 Card 5.7 12-23 m 873 23
YFV Card or history 20.2 12-23 m 941 24 MCV1 Card or History 29.7 12-23 m 873 23
YFV History 6.7 12-23 m 941 24 MCV1 History 24 12-23 m 873 23
Pol1 C or H <12 months 85.5 12-23 m 873 23
Pol1 Card 1.8 12-23 m 873 23
2001 République du Tchad, Revue du Programme Elargi de Vaccination, Pol1 Card or History 90.2 12-23 m 873 23
2002 Pol1 History 88.4 12-23 m 873 23
Pol3 C or H <12 months 42.3 12-23 m 873 23
Pol3 Card 5.6 12-23 m 873 23
Vaccine Confirmation method Coverage Age cohort Sample Cards seen Pol3 Card or History 50.6 12-23 m 873 23
BCG Card or History 51.5 12-23 m 3159 39 Pol3 History 45 12-23 m 873 23
DTP1 Card or History 44 12-23 m 3159 39 YFV C or H <12 months 27.3 12-23 m 873 23
DTP3 Card or History 25.5 12-23 m 3159 39 YFV Card 6.9 12-23 m 873 23
MCV1 Card or History 26 12-23 m 3159 39 YFV Card or History 30.9 12-23 m 873 23
Pol1 Card or History 45.2 12-23 m 3159 39 YFV History 24 12-23 m 873 23
Pol3 Card or History 26 12-23 m 3159 39

July 1, 2023; page 28 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023
 Chad - survey details

Further information and estimates for previous years are available at:
https://data.unicef.org/topic/child-health/immunization/
https://immunizationdata.who.int/listing.html

July 1, 2023; page 29 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2024 data received as of June 26, 2023